University Of California, San Francisco
Clinical trials sponsored by University Of California, San Francisco, explained in plain language.
-
Could less be more? shorter antibiotic course after appendix surgery put to the test
Disease control TerminatedThis trial compares two approaches to antibiotic use after appendix removal surgery: a restrictive course (none or up to 24 hours) versus a liberal course (24 hours to 4 days). The goal is to see if the shorter course is just as safe and effective, while reducing side effects and…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Eye infection breakthrough: new trial tests antivirals to save sight
Disease control TerminatedThis study compared two antiviral medicines (oral valganciclovir and topical ganciclovir 2%) against a placebo for treating CMV-related inflammation in the front of the eye. The goal was to see which approach better controls the infection and reduces complications like pain, glau…
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Young adults with high blood pressure get new drug comparison
Disease control TerminatedThis pilot study tested three common blood pressure medications—amlodipine, chlorthalidone, and losartan—in 36 young adults aged 18-40 with hypertension. Participants took the drugs at home and monitored their blood pressure regularly. The goal was to see which drug works best an…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Kidney cancer drug combo tested before surgery – study halted early
Disease control TerminatedThis study looked at whether giving the immunotherapy drug pembrolizumab (with or without axitinib) before surgery could help control advanced kidney cancer. Only 6 people took part before the study was stopped early. The goal was to see if the treatment boosted immune cells in t…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Mucus-Busting asthma trial fizzles out
Symptom relief TerminatedThis small study tested whether adding n-acetylcysteine (NAC) to albuterol could improve lung function and reduce mucus plugs in people with moderate-to-severe asthma. Only 4 participants were enrolled before the trial was terminated early. The crossover design gave each person t…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Sarcoidosis drug study halted after only 2 patients enrolled
Symptom relief TerminatedThis study tested whether Acthar gel could improve symptoms and lung function in people with sarcoidosis, a disease that causes inflammation in the lungs. Researchers also checked if a blood marker called CXCL9 could predict how well the treatment works. Only 2 people joined befo…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:27 UTC
-
Tiny drops, big hope? study tests nanodropper for glaucoma
Symptom relief TerminatedThis study tested whether a device called Nanodropper, which makes smaller eye drops, works as well as standard eye drops for lowering eye pressure in people with glaucoma or ocular hypertension. The study enrolled 16 adults who already used a common glaucoma drop. The goal was t…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New rehab trick may boost knee recovery after meniscus repair
Symptom relief TerminatedThis study looked at whether adding blood flow restriction training to standard physical therapy helps people regain knee strength and muscle size after meniscus repair surgery. About 15 participants were split into two groups: one did standard rehab, the other added the special …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple pill replace abortion for late periods?
Symptom relief TerminatedThis study tested how acceptable it is to use misoprostol alone to start a late period. It included 17 adults whose period was up to 14 days late. The goal was to see if people were satisfied with this approach and if it worked to bring on their period.
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Sleep therapy tested for Alzheimer's brain fog
Symptom relief TerminatedThis study tested a behavioral program using bright light therapy and sleep coaching to improve sleep and thinking in older adults with mild cognitive impairment or mild Alzheimer's. Only 15 people were enrolled before the study was stopped early. The goal was to see if the progr…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Could a simple drug cut bleeding after mastectomy?
Symptom relief TerminatedThis study tested whether applying tranexamic acid (TXA) directly to the surgical wound during breast removal and reconstruction can reduce bleeding (hematoma) and fluid collections (seroma). These complications can delay healing and cancer treatments. The trial enrolled 23 women…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Sleep study for ICU sedation halted after just 3 volunteers
Knowledge-focused TerminatedThis study aimed to see if a sedative called dexmedetomidine produces sleep more like natural sleep than another sedative, propofol. Researchers planned to measure brain activity in 3 healthy volunteers during drug-induced and natural sleep. The trial was terminated early, so onl…
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Blood test may predict brain fog from prostate cancer treatment
Knowledge-focused TerminatedThis study aimed to see if a simple blood test could predict memory and thinking problems in men with prostate cancer receiving hormone therapy (ADT). Researchers planned to follow 32 men over time, comparing those on ADT to those not on it. The study was stopped early, so result…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Asthma attack study halted: what we almost learned
Knowledge-focused TerminatedThis study aimed to uncover hidden causes of asthma attacks and how inhaled steroids work. Researchers planned to analyze sputum from 67 adults with severe asthma. However, the study was terminated early, so results are limited.
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can cheap text messages boost HIV retesting? pilot study seeks answers
Knowledge-focused TerminatedThis pilot study tested several low-cost behavioral nudges, like videos and text messages, to encourage HIV retesting among 98 adults at higher risk of HIV in rural Kenya and Uganda. The goal was to see which approaches were acceptable and feasible, so the best ones could be used…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Pregnancy pollution link? new study probes environmental cancer risks
Knowledge-focused TerminatedThe DREAM study is an observational research project that enrolled over 1,500 pregnant women and their children to understand how exposure to environmental chemicals—like those in consumer products, air, and water—might influence cancer risk. Researchers collected blood, urine, a…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC